Preparation, characterization and in vitro-in vivo evaluation of bortezomib supermolecular aggregation nanovehicles
- PMID: 32245495
- PMCID: PMC7118915
- DOI: 10.1186/s12951-020-00612-7
Preparation, characterization and in vitro-in vivo evaluation of bortezomib supermolecular aggregation nanovehicles
Abstract
Backgrounds: Intolerable toxicity and unsatisfactory therapeutic effects are still big problems retarding the use of chemotherapy against cancer. Nano-drug delivery system promised a lot in increasing the patients' compliance and therapeutic efficacy. As a unique nano-carrier, supermolecular aggregation nanovehicle has attracted increasing interests due to the following advantages: announcing drug loading efficacy, pronouncing in vivo performance and simplified production process.
Methods: In this study, the supermolecular aggregation nanovehicle of bortezomib (BTZ) was prepared to treat breast cancer.
Results: Although many supermolecular nanovehicles are inclined to disintegrate due to the weak intermolecular interactions among the components, the BTZ supermolecules are satisfying stable. To shed light on the reasons behind this, the forces driving the formation of the nanovehicles were detailed investigated. In other words, the interactions among BTZ and other two components were studied to characterize the nanovehicles and ensure its stability.
Conclusions: Due to the promising tumor targeting ability of the BTZ nanovehicles, the supermolecule displayed promising tumor curing effects and negligible systemic toxicity.
Keywords: Bortezomib (BTZ); Intermolecular interactions; Supermolecular nanovehicles.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Li Jieling, Wang Anhe, Zhao Luyang, Dong Qianqian, Wang Meiyue, Haolan Xu, Yan Xuehai, Bai Shuo. Self-assembly of monomeric hydrophobic photosensitizers with short peptides forming photodynamic nanoparticles with real-time tracking property and without the need of release in vivo. ACS Appl Mater Interfaces. 2018;10(34):28420–28427. doi: 10.1021/acsami.8b09933. - DOI - PubMed
-
- An Lu, Yan Chenglin, Xueling Mu, Tao Cheng, Tian Qiwei, Lin Jiaomin, Yang Shi-Ping. Paclitaxel-induced ultra-small gallic acid-Fe@BSA self-assembly with enhanced MRI performance and tumor accumulation for cancer theranostics. ACS Appl Mater Interfaces. 2019;10(34):28483–28493. doi: 10.1021/acsami.8b10625. - DOI - PubMed
-
- Li Ke, Xiao Gao, Richardson Joseph J, Tardy Blaise L, Ejima Hirotaka, Huang Wen, Guo Junling, Liao Xuepin, Shi Bi. Targeted therapy against metastatic melanoma based on self-assembled metal-phenolic nanocomplexes comprised of green tea catechin. Ad Sci. 2019;6(5):1801688. doi: 10.1002/advs.201801688. - DOI - PMC - PubMed
-
- Zhou Lei, Fan Lei, Yi Xin, Zhou Zhengnan, Liu Can, Ruming Fu, Dai Cong, Wang Zhengao, Chen Xiuxing, Peng Yu, Chen Dafu, Tan Guoxin, Wang Qiyou, Ning Chengyun. Soft conducting polymer hydrogels cross-linked and doped by tannic acid for spinal cord injury repair. ACS Nano. 2018;12(11):10957–10967. doi: 10.1021/acsnano.8b04609. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
